Public company info
Input the stock code or the company name     Search  
 


 Stock code   02181 
 Company name  Mabpharm Limited
 Region  Hong Kong
 Type  MB
 Website  
 Quote  0.0 

Company profile  |  Business review  |  Prospect  |  Latest results  |  Financial ratios
Income statement  |  Cash flow statement  |  Balance sheet  |  Entitlement
Disclosure of interest  |  Quote

 Related stock news
  邁博藥業治療骨質疏鬆症注射液上市申請...  2026-06-10T  
  《業績》邁博藥業全年純利5,713萬...  2026-03-26T  
  《業績》邁博藥業中期純利290萬人民...  2025-08-29T  
  《業績》邁博藥業全年虧損收窄至1.2...  2025-03-27T  
  邁博藥業核心產品CMAB008獲巴基...  2025-01-02T  
  邁博藥業核心產品CMAB008獲印尼...  2024-12-29T  
  《業績》邁博藥業中期虧損收窄至9,7...  2024-08-29T  
  邁博藥業核心產品CMAB008獲秘魯...  2024-07-03T  
  先聲藥業合作注射液產品「恩立妥」獲批...  2024-06-25T  
  邁博藥業：恩立妥獲國家藥監局批准上市  2024-06-25T  
  Search   More 
 Latest News
  南向資金今日淨賣出超106億 港元 ...  2026-08-19T17:  
  ...瑞銀:黃金中期漲勢未完 預計明...  2026-08-19T17:  
  騰訊斥約3億元回購67.3萬股  2026-08-19T  
  《業績》冠君產業信託中期扭虧賺5.4...  2026-08-19T  
  紐約匯市: 美元 隨油價上漲 日元 ...  2026-08-19T05:  
  A50 增強 ETF 富國(5632...  2026-08-19T03:  
  Search   More 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.